BioLargo, Inc.
BLGO
$0.2365
$0.00351.50%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 31.45% | 45.21% | 12.25% | -19.52% | 21.66% |
| Total Depreciation and Amortization | -6.25% | 37.31% | 93.20% | 376.92% | 504.44% |
| Total Amortization of Deferred Charges | -- | -100.00% | -100.00% | -100.00% | -82.35% |
| Total Other Non-Cash Items | -73.18% | -27.16% | 52.23% | 28.90% | -5.95% |
| Change in Net Operating Assets | -66.81% | -115.15% | 117.10% | -301.45% | -268.80% |
| Cash from Operations | -35.56% | 44.36% | 79.05% | -10.57% | 14.37% |
| Capital Expenditure | -158.37% | -220.27% | -429.29% | -350.52% | -76.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -175.52% | -220.27% | -429.29% | -350.52% | -76.38% |
| Total Debt Issued | 1,229.23% | -35.00% | -- | -35.00% | -35.00% |
| Total Debt Repaid | 48.15% | 151.19% | 140.70% | 140.74% | -3.85% |
| Issuance of Common Stock | -5.08% | 23.94% | -20.48% | -27.75% | -17.66% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 24.53% | -97.94% | -78.64% | 207.78% | 615.56% |
| Cash from Financing | -4.74% | -20.04% | -34.40% | -0.98% | 17.77% |
| Foreign Exchange rate Adjustments | 173.44% | -387.50% | -122.22% | 18.75% | -276.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -99.47% | -52.65% | -49.34% | -53.19% | 89.88% |